Vident Investment Advisory’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,745
Closed -$213K 1223
2021
Q2
$213K Buy
+3,745
New +$265K 0.01% 1031
2020
Q1
Sell
-4,031
Closed -$291K 845
2019
Q4
$291K Sell
4,031
-106
-3% -$13K 0.02% 646
2019
Q3
$580K Buy
4,137
+35
+0.9% +$5.86K 0.05% 290
2019
Q2
$751K Buy
4,102
+297
+8% +$50.7K 0.06% 215
2019
Q1
$605K Buy
3,805
+183
+5% +$26.5K 0.03% 511
2018
Q4
$347K Sell
3,622
-230
-6% -$26.3K 0.02% 678
2018
Q3
$544K Sell
3,852
-3,872
-50% -$598K 0.02% 658
2018
Q2
$1.21M Buy
7,724
+961
+14% +$151K 0.05% 392
2018
Q1
$1.1M Buy
+6,763
New +$1.15M 0.04% 377

Other funds holding SAGE